China is witnessing a surge in human metapneumovirus (HMPV) cases, sparking concerns of another health crisis after COVID-19 pandemic

China is seeing a significant increase in human metapneumovirus (HMPV) cases, raising concerns about a potential new health crisis after the COVID-19 pandemic. Reports and social media posts describe overcrowded hospitals, with mentions of various viruses circulating, including HMPV, influenza A, Mycoplasma pneumoniae, and COVID-19.

HMPV is a respiratory virus that causes both upper and lower respiratory infections, affecting people of all ages. However, it is particularly harmful to young children, the elderly, and those with weakened immune systems, according to the CDC. Discovered in 2001, it has become a major health concern due to its severe respiratory effects.

The symptoms of HMPV are similar to those of the flu and other respiratory infections, including cough, fever, nasal congestion, and shortness of breath. In more severe cases, it can lead to complications like bronchitis or pneumonia. The virus typically has an incubation period of three to six days, with symptoms lasting varying lengths of time depending on the severity of the infection.

HMPV spreads in much the same way as other respiratory viruses, through respiratory secretions from coughing and sneezing, close personal contact like shaking hands or touching, and by coming into contact with contaminated surfaces and then touching the face.

Certain groups are more at risk from HMPV, including young children, older adults, and individuals with weakened immune systems, as noted by the CDC.

Preventive measures for HMPV are similar to those for other respiratory viruses. Regular handwashing with soap and water for at least 20 seconds is recommended, along with avoiding touching the face with unwashed hands. It’s also advised to maintain a safe distance from sick individuals and disinfect frequently touched surfaces, such as doorknobs and toys.

Anyone experiencing symptoms of HMPV should follow basic hygiene practices to reduce the virus’s spread. This includes covering the mouth and nose when sneezing or coughing, washing hands frequently, avoiding sharing personal items, and staying at home if feeling unwell to avoid spreading the virus to others.

There is no specific antiviral treatment or vaccine for HMPV at the moment. Medical care generally focuses on relieving symptoms and preventing complications.

HMPV and COVID-19 share similar symptoms, including respiratory issues such as coughing, fever, congestion, sore throat, and shortness of breath. Both viruses spread through respiratory droplets, and severe cases may require hospitalization. However, HMPV typically peaks during the winter and spring months, while COVID-19 can spread year-round due to the presence of evolving variants.